CSL Behring, Australia

  • BuilderMonaco Hickey
  • ArchitectA5 Architects
  • Est. Project Value$40 million
  • Britex Project ManagerMr. Scott Fowler

Britex was engaged by the building contractor to manufacture and install specially fabricated stainless steel fixture for the project. Given the nature of the site we worked closely with the architect and provided consultation on fabrication design methods that met the strict guidelines required for this highly controlled sterile environment. Further to this close collaboration, the process included generating shop drawings, consultation in fixture design, manufacturing each fixture, project managing and coordinating the production of fixtures and installing the fixtures on site in conjunction with the primary contractor.

Stainless steel works and fixtures for the project included:

About the Development

CSL Behring is one of the world’s leading plasma protein biotherapeutic companies specialising in the manufacture of therapies for the treatment of rare and serious diseases. The company’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent haemolytic diseases in newborns.

CSL Behring Australia supports all aspects of the process from the collection and testing of donated plasma through to the production of a range of plasma-derived products. CSL Behring is the chosen national fractionator of Australia, New Zealand, Hong Kong, Malaysia, Singapore and Taiwan.

Source: CSL Website 04/14